Matrix search results
You have found 446 entries after clicking on a search link (usually the MORE information link) in a matrix cell. Starting with the most recently added or updated entries, the list shows in orange the type of entry, year the original document was published (or if one of our own documents, the year last updated), and the type of file you will download when you click on the title. In blue is the document’s title followed by a brief description.
Click blue titles to view full text in a new window Use the selectors at the bottom to turn to the next page in the list of documents Re-order the list by the main topic addressed or by the most recently published documents
If you have not found what you want you could: Select from the full range of topics and search options available on our topic search page.
Instead try a free text search for documents which contain the words you specify.
Or try browsing back issues of the magazine or the more recent email bulletins.
Try the information services provided by partner agencies.
Tried everything? E-mail the Findings editor for help by clicking on this logo 
A randomised trial conducted in England found that the (at the time) recommended three months of supervised consumption of prescribed opioid substitutes like methadone conferred no significant advantages over supervising only for up to the first four weeks of treatment, but the findings applied only to the minority of patients for whom random allocation was thought feasible and safe.
STUDY 2017 HTM file
The evaluation of the Drug Recovery Wing pilots: Final report
The final piece of the Drug Recovery Wing evaluation jigsaw, focusing on the process and impact of implementing the model in eight men’s and two women’s prisons in England and Wales.
STUDY 2018 HTM file
Adult substance misuse statistics from the National Drug Treatment Monitoring System (NDTMS) 1 April 2016 to 31 March 2017
The annual accounting of the treatment caseload in England registers a continuing fall in total numbers and decreasing success with opiate users, while success with drinkers has increased and has for the last few years remained relatively high and stable. An ageing population of opiate users is the proposed explanation for the former trend – but why hasn’t a similarly ageing alcohol caseload also eroded success rates?
MATRIX CELL 2018 HTM file
Drug Treatment Matrix cell E2: Treatment systems; Generic and cross-cutting issues
Seminal and key studies on local, regional and national systems for effectively and cost-effectively providing drug addiction treatment. Commentary focuses on payment-by-results funding mechanisms, crime-reduction as a justification for treatment, and ways to improve treatment systems, especially the core care planning process.
STUDY 2017 HTM file
Does paying service providers by results improve recovery outcomes for drug misusers in treatment in England?
Substance use treatment commissioned on a payment-by-results basis in England has been linked to higher rates of in-treatment abstinence and non-injecting than other commissioning models, but lower rates of treatment initiation and completion. Is this enough to support the policy?
MATRIX CELL 2017 HTM file
Drug Treatment Matrix cell C2: Management/supervision; Generic and cross-cutting issues
Key studies on the role of management and supervision across psychosocial and medical treatments of problem drug use. Highlights that “Manners Matter”, asks, “Is there anything more instructive than being the patient?”, explores the role of patient choice and preferences in treatment planning, and queries the ubiquitous stages of change model. See the rest of row 2 of the matrix for more on features common to psychosocial and medical treatments.
HOT TOPIC 2017 HTM file
Focus on the families
‘Hot topics’ offer background and analysis on important issues which sometimes generate heated debate. Both as a treatment resource for the patient and a group needing support in their own right, a UK report described families affected by substance use as the “forgotten” carers. Here we turn the focus on the “unheard and unseen victims when a loved one uses drugs or alcohol”.
MATRIX CELL 2017 HTM file
Drug Treatment Matrix cell B2: Practitioners; Generic and cross-cutting issues
At the front line the practitioner is to the patient the face of addiction treatment. Key research shows they can matter enormously – not so much in their formal qualifications, but in their manner with the patients. Probe with us the heart of addiction treatment: relationships.
MATRIX CELL 2017 HTM file
Drug Treatment Matrix cell A2: Interventions; Generic and cross-cutting issues
Seminal and key studies on features common to psychosocial therapy/support and medical treatment. Investigates where treatment is aiming to get to in the form of ‘recovery’, where it starts from as depicted in the brain-disease model of addiction, and the politics of the two most important British drug treatment studies.
HOT TOPIC 2017 HTM file
Substance use treatment as part of a ‘wrap-around’ package of care
One of our hot topic essays on important issues which sometimes generate heated debate. Asks whether supplementing addiction treatment with ‘wrap-around’ services is a distraction, or part of the core business of sustainably overcoming addiction. What’s for sure is that mental health, social and material resources, and the wherewithal for social inclusion, are all often lacking in addiction treatment caseloads; but does addressing these promote recovery?
Select search results page
PREVIOUS
|
NEXT
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45